These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31776333)

  • 1. Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies.
    Tytgat HLP; Lin CW; Levasseur MD; Tomek MB; Rutschmann C; Mock J; Liebscher N; Terasaka N; Azuma Y; Wetter M; Bachmann MF; Hilvert D; Aebi M; Keys TG
    Nat Commun; 2019 Nov; 10(1):5403. PubMed ID: 31776333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of secretory and extracellular N-linked glycoproteins in Escherichia coli.
    Fisher AC; Haitjema CH; Guarino C; Çelik E; Endicott CE; Reading CA; Merritt JH; Ptak AC; Zhang S; DeLisa MP
    Appl Environ Microbiol; 2011 Feb; 77(3):871-81. PubMed ID: 21131519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial Glycoengineering as a Biosynthetic Route to Customized Glycomolecules.
    Yates LE; Mills DC; DeLisa MP
    Adv Biochem Eng Biotechnol; 2021; 175():167-200. PubMed ID: 30099598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoengineering of CHO Cells to Improve Product Quality.
    Wang Q; Yin B; Chung CY; Betenbaugh MJ
    Methods Mol Biol; 2017; 1603():25-44. PubMed ID: 28493121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and process engineering strategies for enhanced recombinant N-glycoprotein production in bacteria.
    Pratama F; Linton D; Dixon N
    Microb Cell Fact; 2021 Oct; 20(1):198. PubMed ID: 34649588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biosynthetic route for polysialylating proteins in Escherichia coli.
    Keys TG; Wetter M; Hang I; Rutschmann C; Russo S; Mally M; Steffen M; Zuppiger M; Müller F; Schneider J; Faridmoayer A; Lin CW; Aebi M
    Metab Eng; 2017 Nov; 44():293-301. PubMed ID: 29101090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli.
    Harding CM; Feldman MF
    Glycobiology; 2019 Jul; 29(7):519-529. PubMed ID: 30989179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cell-free biosynthesis platform for modular construction of protein glycosylation pathways.
    Kightlinger W; Duncker KE; Ramesh A; Thames AH; Natarajan A; Stark JC; Yang A; Lin L; Mrksich M; DeLisa MP; Jewett MC
    Nat Commun; 2019 Nov; 10(1):5404. PubMed ID: 31776339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Markov chain model for N-linked protein glycosylation--towards a low-parameter tool for model-driven glycoengineering.
    Spahn PN; Hansen AH; Hansen HG; Arnsdorf J; Kildegaard HF; Lewis NE
    Metab Eng; 2016 Jan; 33():52-66. PubMed ID: 26537759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Producing a glycosylating Escherichia coli cell factory: The placement of the bacterial oligosaccharyl transferase pglB onto the genome.
    Strutton B; Jaffé SRP; Pandhal J; Wright PC
    Biochem Biophys Res Commun; 2018 Jan; 495(1):686-692. PubMed ID: 29113801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse Metabolic Engineering for Enhanced Glycoprotein Production in Escherichia coli.
    Jaffé SR; Strutton B; Pandhal J; Wright PC
    Methods Mol Biol; 2015; 1321():17-35. PubMed ID: 26082212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A filamentous phage display system for N-linked glycoproteins.
    Celik E; Fisher AC; Guarino C; Mansell TJ; DeLisa MP
    Protein Sci; 2010 Oct; 19(10):2006-13. PubMed ID: 20669235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant glycoengineering for designing next-generation vaccines and therapeutic proteins.
    Strasser R
    Biotechnol Adv; 2023 Oct; 67():108197. PubMed ID: 37315875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of therapeutic glycoproteins in glycoengineered plant: old farm for new crops.
    Kao MR; Karmarkar Saldivar R; Hsieh YSY
    Curr Opin Biotechnol; 2024 Jun; 87():103145. PubMed ID: 38781701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted glycoengineering extends the protein N-glycosylation pathway in the silkworm silk gland.
    Mabashi-Asazuma H; Sohn BH; Kim YS; Kuo CW; Khoo KH; Kucharski CA; Fraser MJ; Jarvis DL
    Insect Biochem Mol Biol; 2015 Oct; 65():20-7. PubMed ID: 26163436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new insect cell line engineered to produce recombinant glycoproteins with cleavable N-glycans.
    Mabashi-Asazuma H; Jarvis DL
    J Biol Chem; 2022 Jan; 298(1):101454. PubMed ID: 34838817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Free Systems for the Production of Glycoproteins.
    Bidstrup EJ; Kwon YH; Kim K; Bandi CK; Aw R; Jewett MC; DeLisa MP
    Methods Mol Biol; 2024; 2762():309-328. PubMed ID: 38315374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic N-glycosyltransferase of Actinobacillus pleuropneumoniae is an inverting enzyme and recognizes the NX(S/T) consensus sequence.
    Schwarz F; Fan YY; Schubert M; Aebi M
    J Biol Chem; 2011 Oct; 286(40):35267-74. PubMed ID: 21852240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic glycoengineering in mammalian cells.
    Narimatsu Y; Büll C; Chen YH; Wandall HH; Yang Z; Clausen H
    J Biol Chem; 2021; 296():100448. PubMed ID: 33617880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of exogenous bacterial oligosaccharyltransferases in Escherichia coli reveals the potential for O-linked protein glycosylation in Vibrio cholerae and Burkholderia thailandensis.
    Gebhart C; Ielmini MV; Reiz B; Price NL; Aas FE; Koomey M; Feldman MF
    Glycobiology; 2012 Jul; 22(7):962-74. PubMed ID: 22391990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.